FDA inspection
McGuff Pharmaceuticals, Inc.: FDA inspection ending Apr 28, 2025
FDA inspection 1268175 · Official Action Indicated (OAI) · Santa Ana, CA
Key facts
| Inspection ID | 1268175 |
|---|---|
| Firm | McGuff Pharmaceuticals, Inc. |
| FEI number | 2022073 |
| Address | 2921 W Macarthur Blvd Ste 141 |
| City | Santa Ana |
| State | CA |
| ZIP | 92704 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Apr 28, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data